Response to Imatinib in a Patient with Double-mutant KIT Metastatic Penile Melanoma
Saved in:
Main Authors: | Olivia Beaudoux (Author), Marine Ehret (Author), Emilie Criquet (Author), Joséphine Franceschi (Author), Anne Durlach (Author), Jean-Bapstiste Oudart (Author), Laetitia Visseaux (Author), Florent Grange (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas
by: Joséphine Franceschi, et al.
Published: (2022) -
Imatinib inhibits migration of normal human epidermal melanocytes and suppress the phosphorylation of C-kit
by: Jian-Xin Xia, et al.
Published: (2012) -
Metastatic penile carcinoma associated with convergent gain-of-function mutations in NOTCH1
by: Sabina Signoretti, et al.
Published: (2018) -
Diffuse cutaneous mastocytosis in a girl with M541L polymorphism in KIT gene: Response to treatment with imatinib
by: Aniza Giacaman, et al.
Published: (2023) -
Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity
by: Ashraf K. El-Damasy, et al.
Published: (2023)